Published :
Tables : 58
Figures : 52
Category : Healthcare
No. of Pages : 248
Report Code : HC-U5546
Pharmaceutical Manufacturing Market is poised to value over CAGR of over 11.34% during the forecast period 2022 to 2028. FutureWise Market Research has instantiated a report that provides an intricate analysis of Pharmaceutical Manufacturing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Pharmaceutical Manufacturing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Pharmaceutical Manufacturing Market: • F. Hoffmann-La Roche Ltd. • Novartis AG • GlaxoSmithKline plc • Pfizer, Inc. • AstraZeneca • Merck & Co., Inc. • Johnson & Johnson • Sanofi SA • Eli Lilly and Company • Lonza (Note: The list of the major players will be updated with the latest market scenario and trends) Pharmaceutical Manufacturing Market Segmentation: By Drug Development Type • Outsource • In-house By Formulation • Tablets • Capsules • Injectable • Sprays • Suspensions • Powders • Other Formulations By Route of Administration • Oral • Topical • Parenteral • Inhalations • Other Routes of Administration By Therapy Area • Cardiovascular Diseases • Pain • Diabetes • Cancer • Respiratory Diseases • Other Diseases By Prescription • Prescription Medicines • Over-the-counter (OTC) Medicines By Age Group • Children & Adolescents • Adults • Geriatric By Disrtribution Channel • Retail • Non-retail By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Pharmaceutical Manufacturing Market By Drug Development Type, By Formulation, By Route of Administration, By Therapy Area, By Prescription, By Age Group, By Disrtribution Channel and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Pharmaceutical Manufacturing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Pharmaceutical Manufacturing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Pharmaceutical Manufacturing Market: • F. Hoffmann-La Roche Ltd. • Novartis AG • GlaxoSmithKline plc • Pfizer, Inc. • AstraZeneca • Merck & Co., Inc. • Johnson & Johnson • Sanofi SA • Eli Lilly and Company • Lonza (Note: The list of the major players will be updated with the latest market scenario and trends) Pharmaceutical Manufacturing Market Segmentation: By Drug Development Type • Outsource • In-house By Formulation • Tablets • Capsules • Injectable • Sprays • Suspensions • Powders • Other Formulations By Route of Administration • Oral • Topical • Parenteral • Inhalations • Other Routes of Administration By Therapy Area • Cardiovascular Diseases • Pain • Diabetes • Cancer • Respiratory Diseases • Other Diseases By Prescription • Prescription Medicines • Over-the-counter (OTC) Medicines By Age Group • Children & Adolescents • Adults • Geriatric By Disrtribution Channel • Retail • Non-retail By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Pharmaceutical Manufacturing Market By Drug Development Type, By Formulation, By Route of Administration, By Therapy Area, By Prescription, By Age Group, By Disrtribution Channel and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Pharmaceutical Manufacturing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Pharmaceutical Manufacturing Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Pharmaceutical Manufacturing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Pharmaceutical Manufacturing Market, By Drug Development Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Outsource 7.2. In-house 8. Global Pharmaceutical Manufacturing Market, By Formulation Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Tablets 8.2. Capsules 8.3. Injectable 8.4. Sprays 8.5. Suspensions 8.6. Powders 8.7.Other Formulations 9. Global Pharmaceutical Manufacturing Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Oral 9.2. Topical 9.3. Parenteral 9.4. Inhalations 9.5. Other Routes of Administration 10. Global Pharmaceutical Manufacturing Market, By Therapy Area Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Cardiovascular Diseases 10.2. Pain 10.3. Diabetes 10.4. Cancer 10.5. Respiratory Diseases 10.6. Other Diseases 11. Global Pharmaceutical Manufacturing Market, By Prescription Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Prescription Medicines 11.2. Over-the-counter (OTC) Medicines 12. Global Pharmaceutical Manufacturing Market, By Age Group Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. Children & Adolescents 12.2. Adults 12.3. Geriatric 13. Global Pharmaceutical Manufacturing Market, By Disrtribution Channel Historical Analysis and Forecast 2022-2028 (USD Million) 13.1. Retail 13.2. Non-retail 14. North America Pharmaceutical Manufacturing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. U.S.A 14.2.2. Canada 14.2.3. Mexico 14.3. Market Size (USD Million) Forecast for North America 2022-2028 15. Latin America Pharmaceutical Manufacturing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Brazil 15.2.2. Venezuela 15.2.3. Argentina 15.2.4. Rest of Latin America 15.3. Market Size (USD Million) Forecast for Latin America 2022-2028 16. Europe Pharmaceutical Manufacturing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Germany 16.2.2. U.K 16.2.3. France 16.2.4. Italy 16.2.5. Spain 16.2.6. Russia 16.2.7. Poland 16.2.8. Rest of Europe 16.3. Market Size (USD Million) Forecast for Europe 2022-2028 17. Asia Pacific Pharmaceutical Manufacturing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. Japan 17.2.2. China 17.2.3. India 17.2.4. Australia and New Zealand 17.2.5. ASEAN 17.2.6. Rest of Asia Pacific 17.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 18. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 18.1. Introduction 18.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 18.2.1. GCC 18.2.2. Israel 18.2.3. South Africa 18.2.4. Rest of MEA 18.3. Market Size (USD Million) Forecast for MEA 2022-2028 19. Market Share Analysis and Competitive Landscape 19.1. Global Landscape - Key Players, Revenue and Presence 19.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 19.3. Global Emerging Companies 19.4. North America - Market Share Analysis and Key Regional Players 19.5. Europe - Market Share Analysis and Key Regional Players 19.6. Asia Pacific - Market Share Analysis and Key Regional Players 19.7. Global Key Player - Growth Matrix 20. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 20.1. F. Hoffmann-La Roche Ltd. 20.1.1. Company Overview 20.1.2. Product Portfolio 20.1.3. SWOT Analysis 20.1.4. Financial Overview 20.1.5. Strategic Overview 20.2. Novartis AG 20.2.1. Company Overview 20.2.2. Product Portfolio 20.2.3. SWOT Analysis 20.2.4. Financial Overview 20.2.5. Strategic Overview 20.3. GlaxoSmithKline plc 20.3.1. Company Overview 20.3.2. Product Portfolio 20.3.3. SWOT Analysis 20.3.4. Financial Overview 20.3.5. Strategic Overview 20.4. Pfizer, Inc. 20.4.1. Company Overview 20.4.2. Product Portfolio 20.4.3. SWOT Analysis 20.4.4. Financial Overview 20.4.5. Strategic Overview 20.5. AstraZeneca 20.5.1. Company Overview 20.5.2. Product Portfolio 20.5.3. SWOT Analysis 20.5.4. Financial Overview 20.5.5. Strategic Overview 20.6. Merck & Co., Inc. 20.6.1. Company Overview 20.6.2. Product Portfolio 20.6.3. SWOT Analysis 20.6.4. Financial Overview 20.6.5. Strategic Overview 20.7. Johnson & Johnson 20.7.1. Company Overview 20.7.2. Product Portfolio 20.7.3. SWOT Analysis 20.7.4. Financial Overview 20.7.5. Strategic Overview 20.8. Sanofi SA 20.8.1. Company Overview 20.8.2. Product Portfolio 20.8.3. SWOT Analysis 20.8.4. Financial Overview 20.8.5. Strategic Overview 20.9. Eli Lilly and Company 20.9.1. Company Overview 20.9.2. Product Portfolio 20.9.3. SWOT Analysis 20.9.4. Financial Overview 20.9.5. Strategic Overview 20.10. Lonza 20.10.1. Company Overview 20.10.2. Product Portfolio 20.10.3. SWOT Analysis 20.10.4. Financial Overview 20.10.5. Strategic Overview 21. Pre and Post COVID-19 Impact 21.1. Positive influence on the healthcare industry 21.2. The financial disruption of the manufacturing sector 21.3. Impact of COVID-19 on emerging companies 21.4. Significant mandates in the healthcare regulations initiated by administrations 21.5. The overall economic slowdown of the developing and developed nations 22. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Pharmaceutical Manufacturing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Pharmaceutical Manufacturing Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Pharmaceutical Manufacturing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Pharmaceutical Manufacturing Market, By Drug Development Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Outsource 7.2. In-house
8. Global Pharmaceutical Manufacturing Market, By Formulation Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Tablets 8.2. Capsules 8.3. Injectable 8.4. Sprays 8.5. Suspensions 8.6. Powders 8.7.Other Formulations
9. Global Pharmaceutical Manufacturing Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Oral 9.2. Topical 9.3. Parenteral 9.4. Inhalations 9.5. Other Routes of Administration
10. Global Pharmaceutical Manufacturing Market, By Therapy Area Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Cardiovascular Diseases 10.2. Pain 10.3. Diabetes 10.4. Cancer 10.5. Respiratory Diseases 10.6. Other Diseases
11. Global Pharmaceutical Manufacturing Market, By Prescription Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Prescription Medicines 11.2. Over-the-counter (OTC) Medicines
12. Global Pharmaceutical Manufacturing Market, By Age Group Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. Children & Adolescents 12.2. Adults 12.3. Geriatric
13. Global Pharmaceutical Manufacturing Market, By Disrtribution Channel Historical Analysis and Forecast 2022-2028 (USD Million) 13.1. Retail 13.2. Non-retail
14. North America Pharmaceutical Manufacturing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. U.S.A 14.2.2. Canada 14.2.3. Mexico 14.3. Market Size (USD Million) Forecast for North America 2022-2028
15. Latin America Pharmaceutical Manufacturing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Brazil 15.2.2. Venezuela 15.2.3. Argentina 15.2.4. Rest of Latin America 15.3. Market Size (USD Million) Forecast for Latin America 2022-2028
16. Europe Pharmaceutical Manufacturing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Germany 16.2.2. U.K 16.2.3. France 16.2.4. Italy 16.2.5. Spain 16.2.6. Russia 16.2.7. Poland 16.2.8. Rest of Europe 16.3. Market Size (USD Million) Forecast for Europe 2022-2028
17. Asia Pacific Pharmaceutical Manufacturing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. Japan 17.2.2. China 17.2.3. India 17.2.4. Australia and New Zealand 17.2.5. ASEAN 17.2.6. Rest of Asia Pacific 17.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
18. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 18.1. Introduction 18.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 18.2.1. GCC 18.2.2. Israel 18.2.3. South Africa 18.2.4. Rest of MEA 18.3. Market Size (USD Million) Forecast for MEA 2022-2028
19. Market Share Analysis and Competitive Landscape 19.1. Global Landscape - Key Players, Revenue and Presence 19.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 19.3. Global Emerging Companies 19.4. North America - Market Share Analysis and Key Regional Players 19.5. Europe - Market Share Analysis and Key Regional Players 19.6. Asia Pacific - Market Share Analysis and Key Regional Players 19.7. Global Key Player - Growth Matrix
20. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 20.1. F. Hoffmann-La Roche Ltd. 20.1.1. Company Overview 20.1.2. Product Portfolio 20.1.3. SWOT Analysis 20.1.4. Financial Overview 20.1.5. Strategic Overview 20.2. Novartis AG 20.2.1. Company Overview 20.2.2. Product Portfolio 20.2.3. SWOT Analysis 20.2.4. Financial Overview 20.2.5. Strategic Overview 20.3. GlaxoSmithKline plc 20.3.1. Company Overview 20.3.2. Product Portfolio 20.3.3. SWOT Analysis 20.3.4. Financial Overview 20.3.5. Strategic Overview 20.4. Pfizer, Inc. 20.4.1. Company Overview 20.4.2. Product Portfolio 20.4.3. SWOT Analysis 20.4.4. Financial Overview 20.4.5. Strategic Overview 20.5. AstraZeneca 20.5.1. Company Overview 20.5.2. Product Portfolio 20.5.3. SWOT Analysis 20.5.4. Financial Overview 20.5.5. Strategic Overview 20.6. Merck & Co., Inc. 20.6.1. Company Overview 20.6.2. Product Portfolio 20.6.3. SWOT Analysis 20.6.4. Financial Overview 20.6.5. Strategic Overview 20.7. Johnson & Johnson 20.7.1. Company Overview 20.7.2. Product Portfolio 20.7.3. SWOT Analysis 20.7.4. Financial Overview 20.7.5. Strategic Overview 20.8. Sanofi SA 20.8.1. Company Overview 20.8.2. Product Portfolio 20.8.3. SWOT Analysis 20.8.4. Financial Overview 20.8.5. Strategic Overview 20.9. Eli Lilly and Company 20.9.1. Company Overview 20.9.2. Product Portfolio 20.9.3. SWOT Analysis 20.9.4. Financial Overview 20.9.5. Strategic Overview 20.10. Lonza 20.10.1. Company Overview 20.10.2. Product Portfolio 20.10.3. SWOT Analysis 20.10.4. Financial Overview 20.10.5. Strategic Overview
21. Pre and Post COVID-19 Impact 21.1. Positive influence on the healthcare industry 21.2. The financial disruption of the manufacturing sector 21.3. Impact of COVID-19 on emerging companies 21.4. Significant mandates in the healthcare regulations initiated by administrations 21.5. The overall economic slowdown of the developing and developed nations
22. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics